• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Lung Cancer

Liver Cancer Awareness – Here’s What You Need to Know in 2023

by Justin Chen Li, CEO of Helio Genomics 01/06/2023 Leave a Comment

Liver Cancer Awareness – Here’s What You Need to Know in 2023

By the end of 2022, nearly 42,00 new cases of primary liver cancer will be diagnosed in the United States. In fact, liver cancer incidence rates have more than tripled since 1980, marking an increased need for better detection and diagnosis.  We might not talk about liver cancer as much as we do breast or lung cancer, but it’s a real threat to millions of Americans – and we need to continue spreading awareness.  Early detection is especially critical in treating liver cancer.
Read More

Oatmeal Health Brings AI-Powered Lung Cancer Screening to The Clinic in Oklahoma

by Jasmine Pennic 11/21/2022 Leave a Comment

Oatmeal Health Brings AI-Powered Lung Cancer Screening to The Clinic in Oklahoma

What You Should Know: - Central Oklahoma Family Medical Center FQHC (The Clinic) has selected Oatmeal Health, a veteran-owned Patient Success Service to bring tech-enabled lung cancer screenings to their patients. - As part of the partnership, Oatmeal Health will provide white-glove, concierge service, offering our support without FQHC’s shouldering the burden or cost.  Tech-Enabled Lung Cancer Screening Currently, lung screening rates hover at around 4 percent
Read More

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

by Syed Hamza Sohail 10/13/2022 Leave a Comment

ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics

What You Should Know: - ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The company will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung. Its close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions it to research and develop
Read More

Optellum Raises $14M for AI-Enabled Lung Cancer Diagnosis

by Fred Pennic 09/27/2022 Leave a Comment

Optellum Raises $14M for AI-Enabled Lung Cancer Diagnosis

What You Should Know: - Optellum, an Oxford-based digital health company that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer raises $14M in Series A funding led by Mercia, with additional investors Intuitive Ventures and Black Opal Ventures. Existing investors, including St John's College in the University of Oxford, IQ Capital, and the family office of Sir Martin & Lady Audrey Wood, also participated in this round. - The investment will enable
Read More

Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data

by Syed Hamza Sohail 09/12/2022 Leave a Comment

Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data

What You Should Know: - Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers. - The study will encompass both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition,
Read More

Intelerad Acquires PenRad Technologies

by Fred Pennic 08/16/2022 Leave a Comment

Intelerad Acquires PenRad Technologies

What You Should Know: - Today, Intelerad, a leading global provider of enterprise medical imaging solutions, announced its acquisition of PenRad, a software provider for enhancing productivity for breast imaging and lung screening. - The acquisition expands Intelerad’s product offerings for mammography and lung analytics, ensuring radiologists, technologists and other healthcare professionals can drive greater productivity and meet higher oncology screening demand, while improving patient
Read More

UCLA Research Uses Saliva to Detect Cancer Biomarkers

by Syed Hamza Sohail 07/27/2022 Leave a Comment

UCLA Health’s COVID-19 Swab Shortage Solved With 3D-Printed Swabs

What You Should Know: - Spectrum Solutions, LLC announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry that successfully demonstrated a superior ability to detect circulating tumor DNA (ctDNA) from saliva. - Specifically, amplified EGFR mutations associated with non-small cell lung cancer (NSCLC) using Spectrum’s saliva collection and preservation system with the Electric
Read More

$3.7 Trillion Reasons to Centralize Chronic Disease Management

by Ty Vachon M.D., Cofounder at Oatmeal Health 07/13/2022 Leave a Comment

3.7-Trillion-Reasons-to-Centralize-Chronic-Disease-Management

59% of all Americans (194 million) suffer from at least one chronic disease, and almost one in three adults has three or more chronic conditions.  Unfortunately, the problem will only get worse with time.  On the business front of chronic disease management, health care systems are already struggling with rising costs and uneven quality despite the hard work of well-intentioned, well-trained clinicians.  Health care leaders and policymakers have tried countless
Read More

Potential of Implementing Polygenic Risk Scores in Healthcare Systems

by Dr George Busby, co-founder and Chief Scientific Officer at Allelica 04/06/2022 Leave a Comment

Challenges and Potential of Implementing Polygenic Risk Scores in US Healthcare Systems

The promise of personalized medicine is a world in which interventions, screening, and therapeutics are targeted to those most likely to get the disease. Polygenic risk scores will help society reach this ambition by accurately assessing the contribution that one’s DNA makes to disease risk.  When Thomas Jefferson wrote in the Declaration of Independence that ‘all men are created equal,’ he captured the essential concept of equality on which the US Constitution is based. Although no one would
Read More

COTA Promotes Miruna Sasu to President and CEO

by Digital Health Executive Appointments 03/24/2022 Leave a Comment

COTA Promotes Miruna Sasu to President and CEO

What You Should Know: - COTA, Inc., an oncology real-world data and analytics company, announced today that Miruna Sasu, Ph.D., MBA, has been appointed president and chief executive officer.  - Since April 2021 when she was hired as the company’s chief strategy officer, Miruna has helped spearhead a series of research collaborations focused on investigating racial disparities in cancer care and the drug development process, including partnerships with the University of Chicago
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |